Workflow
非甾体类局部用药替代皮质类固醇
icon
Search documents
Arcutis Biotherapeutics (NasdaqGS:ARQT) 2025 Earnings Call Transcript
2025-10-28 15:32
Arcutis Biotherapeutics (NasdaqGS:ARQT) 2025 Earnings Call October 28, 2025 10:30 AM ET Company ParticipantsFrank Watanabe - President and CEOTodd Edwards - Chief Commercial OfficerLatha Vairavan - CFOBrian Schoelkopf - Head of Investor RelationsDouglas DiRuggiero - Certified Physician Assistant and Doctor of Medical SciencePatrick Burnett - Chief Medical OfficerOperatorToday, and thank you for standing by. Welcome to the Arcutis Biotherapeutics 2025 third quarter financial results and investor day presenta ...